Efficacy of prednisone combined with mycophenolate mofetil for immunoglobulin A nephropathy with moderate-to-severe renal dysfunction

Table 1 Baseline data of patients in the different treatment groups

Project	GTG	ITG	t value	P value
Male:Female	60:40	61:39	0.021	0.885
Age (yr)	33.15 ± 9.91	34.42 ± 10.04	-0.901	0.369
DBP (mmHg)	93.05 ± 6.98	93.03 ± 7.73	0.019	0.985
SBP (mmHg)	140.60 ± 9.94	141.40 ± 11.17	-0.535	0.593
K (mmol/L)	4.88 ± 0.97	4.72 ± 0.96	1.149	0.252
Hb (g/L)	128.60 ± 14.97	129.65 ± 16.29	-0.472	0.638
GFR (mL-1min-1∙(1.73∙m2)-1)	55.36 ± 3.34	54.70 ± 3.27	1.405	0.162
ALT (U/L)	36.53 ± 3.20	37.12 ± 3.30	-1.279	0.203
T-CHO (mmol/L)	5.59 ± 0.99	5.55 ± 0.99	0.321	0.748
Glu (mmol/L)	5.19 ± 0.69	5.10 ± 0.66	0.883	0.378
BMI (kg/m2)	23.06 ± 2.51	23.29 ± 2.55	-0.717	0.474
Alb (g/L)	22.94 ± 3.20	23.11 ± 3.02	-0.402	0.688
24-h urinary protein quantification (g)	4.01 ± 1.43	3.86 ± 1.37	0.76	0.448
Scr (μmol/L)	121.51 ± 14.58	122.16 ± 15.29	-0.311	0.756

GTG: Glucocorticoid therapy group; ITG: Immunosuppressive therapy group; DBP: Diastolic blood pressure; SBP: Systolic blood pressure; Scr: Serum creatinine; UA: Blood uric acid; BLA: Blood albumin; K: Blood potassium; Hb: Hemoglobin; eGFR: Glomerular filtration rate; ALT: Alanine aminotransferase; T-CHO: Total cholesterol; Glu: Fasting blood glucose; BMI: Body mass index.